David McElroy
Vorstandsvorsitzender bei Green Bioactives Ltd.
Vermögen: 15 Mio $ am 31.05.2024
Profil
David McElroy is the founder of Calysta, Inc. He is currently the Chief Executive Officer at Green Bioactives Ltd.
His former positions include Senior Director-Business Development at DuPont Pioneer, and Principal at Maxygen, Inc. and Verdia, Inc. He received his undergraduate degree from the University of Aberdeen and his doctorate from Cornell University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
27.02.2024 | 188 324 ( 0,03% ) | 15 Mio $ | 31.05.2024 |
Aktive Positionen von David McElroy
Unternehmen | Position | Beginn |
---|---|---|
Green Bioactives Ltd.
Green Bioactives Ltd. Household/Personal CareConsumer Non-Durables The British company's platform provides sustainable access to a diverse library of bioactives for commercial applications in the cosmetics, pharma, food, and agricultural industries. Green Bioactives Ltd. works with several world-leading partners to produce high-value bioactives that cannot be produced sustainably or economically using other approaches. The company was founded in 2019 by Gary Loake, and David McElroy has been the CEO of the company since 2021. | Vorstandsvorsitzender | 01.12.2021 |
Ehemalige bekannte Positionen von David McElroy
Unternehmen | Position | Ende |
---|---|---|
Calysta, Inc.
Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Gründer | - |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - |
Verdia, Inc.
Verdia, Inc. Miscellaneous ManufacturingProducer Manufacturing Verdia, Inc. manufactures polymer flooring and coating. It Products are used in educational and institutional organizations, airports and food and beverage processing. The company was founded in 2014 and is headquartered in Conroe, TX. | Corporate Officer/Principal | - |
DuPont Pioneer
DuPont Pioneer Wholesale DistributorsDistribution Services DuPont Pioneer develops, markets and sells hybrid seeds. It provides argonomic support and services to farmers and strives to develop sustainable agricultural systems. The company was founded in 1926 and is headquartered in Johnston, IA. | Corporate Officer/Principal | - |
Ausbildung von David McElroy
Cornell University | Doctorate Degree |
University of Aberdeen | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
DuPont Pioneer
DuPont Pioneer Wholesale DistributorsDistribution Services DuPont Pioneer develops, markets and sells hybrid seeds. It provides argonomic support and services to farmers and strives to develop sustainable agricultural systems. The company was founded in 1926 and is headquartered in Johnston, IA. | Distribution Services |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Verdia, Inc.
Verdia, Inc. Miscellaneous ManufacturingProducer Manufacturing Verdia, Inc. manufactures polymer flooring and coating. It Products are used in educational and institutional organizations, airports and food and beverage processing. The company was founded in 2014 and is headquartered in Conroe, TX. | Producer Manufacturing |
Calysta, Inc.
Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Process Industries |
Green Bioactives Ltd.
Green Bioactives Ltd. Household/Personal CareConsumer Non-Durables The British company's platform provides sustainable access to a diverse library of bioactives for commercial applications in the cosmetics, pharma, food, and agricultural industries. Green Bioactives Ltd. works with several world-leading partners to produce high-value bioactives that cannot be produced sustainably or economically using other approaches. The company was founded in 2019 by Gary Loake, and David McElroy has been the CEO of the company since 2021. | Consumer Non-Durables |